All Nektar Therapeutics articles
-
Business
BMS stimulates cancer drug hopes with giant collaboration
Immunooncology pioneer will pay up to $3.6bn in hope Nektar drug will help non-responders
Immunooncology pioneer will pay up to $3.6bn in hope Nektar drug will help non-responders